Daniel A. Vallera

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function

Daniel A. Vallera, Martin Felices, Ron McElmurry et al. · Clinical Cancer Research · 2016 · 368 citations · Full text

Life Sciences, Immunology, Oncology +17

Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia

John H. Kersey, Daniel Weisdorf, Mark E. Nesbit et al. · New England Journal of Medicine · 1987 · 333 citations

Medicine, Hematology, Oncology +15

Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia

Qing Zhou, Meghan E. Munger, Steven L. Highfill et al. · Blood · 2010 · 285 citations · Full text

Life Sciences, Immunology, Oncology +14

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets

Michelle Gleason, Julie A. Ross, Erica D. Warlick et al. · Blood · 2014 · 258 citations · Full text

Life Sciences, Cell Biology, Immunology +13

3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments

Fanben Meng, Carolyn Meyer, Daeha Joung et al. · Advanced Materials · 2019 · 256 citations

Medicine, Cancer Biology, Oncology +17